|
ANG Lifesciences India Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
43.09 Cr.
|
P/BV
|
0.89
|
Book Value (Rs.)
|
37.25
|
|
52 Week High/Low (Rs.)
|
50/18
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 92.89 | 92.85 | 146.11 | 219.89 | 354.12 |
| Other Operating Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 |
| Total Operating Revenues | 92.89 | 92.85 | 146.11 | 219.89 | 354.30 |
| | | | | | |
| Other Income | 0.54 | 2.02 | 0.70 | 9.72 | 0.90 |
| Total Revenue | 93.44 | 94.87 | 146.81 | 229.61 | 355.20 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 57.34 | 63.90 | 102.79 | 156.08 | 234.65 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 3.20 | -4.28 | -7.67 | -5.49 | -6.67 |
| Employee Benefit Expenses | 16.54 | 17.45 | 19.35 | 23.97 | 21.29 |
| Finance Costs | 7.93 | 8.70 | 10.95 | 11.88 | 8.91 |
| Depreciation And Amortisation Expenses | 6.33 | 6.76 | 8.37 | 9.35 | 5.88 |
| Other Expenses | 15.11 | 18.04 | 22.00 | 31.20 | 37.65 |
| Total Expenses | 106.45 | 110.57 | 155.79 | 226.99 | 301.70 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -13.01 | -15.70 | -8.98 | 2.63 | 53.50 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | -1.74 | 0.00 | 0.00 |
| Profit/Loss Before Tax | -13.01 | -15.70 | -10.71 | 2.63 | 53.50 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | -1.93 | 0.00 | 0.00 | 2.11 | 13.47 |
| Deferred Tax | 0.00 | -3.29 | -0.57 | 0.78 | -0.28 |
| Total Tax Expenses | -1.93 | -3.29 | -0.57 | 2.89 | 13.18 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -11.08 | -12.41 | -10.14 | -0.26 | 40.32 |
| | | | | | |
| Profit/Loss From Continuing Operations | -11.08 | -12.41 | -10.14 | -0.26 | 40.32 |
| | | | | | |
| Profit/Loss For The Period | -11.08 | -12.41 | -10.14 | -0.26 | 40.32 |
| Consolidated Profit/Loss After MI And Associates | -11.08 | -12.41 | -10.14 | -0.26 | 40.32 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -8.43 | -9.42 | -7.65 | 0.36 | 39.39 |
| Diluted EPS (Rs.) | -8.43 | -9.42 | -7.65 | 0.36 | 39.09 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 1.04 |
